Navigation Links
HerbalScience Releases Results of Pilot Clinical Study on Efficacy of Its Proprietary Elderberry Extract in Addressing Flu-Like Symptoms
Date:10/6/2009

NAPLES, Fla., Oct. 6 /PRNewswire/ -- The ability of a proprietary elderberry extract to significantly reduce flu-like symptoms was demonstrated in a double-blind, placebo-controlled study, undertaken on behalf of HerbalScience Group LLC. The pilot, randomized clinical trial was conducted by Dr. Fan-kun Kong, assisted by medical personnel at Shanghai Construction Technical College, China. The study took place during the spring 2009 flu season and involved 64 patients ranging in age from 16 to 60 years.

At the time of enrollment in the study, each of the 64 patients had had three or more flu-like symptoms (fever, headache, muscle aches, coughing, nasal mucus discharge, and nasal congestion) for less than 24 hours. Patients were randomized into two groups and for two days were given four doses daily of the proprietary elderberry extract developed by HerbalScience or a placebo. Patients were asked to self-assess their symptoms at specific intervals over the two days, scoring the severity of symptoms on a Visual Analogue Scale (VAS), with "0" equal to no problem and "10" equal to a pronounced problem.

"By 48 hours, nine patients (28%) in the group receiving the elderberry extract were symptom-free, 19 patients (60%) showed relief from some symptoms and had only one or two mild symptoms (VAS=1), while the remaining four showed symptom improvement but to a lesser degree," said Dr. Kong. "By contrast, complete recovery was not achieved by a single patient in the placebo group, and only 16% showed improvement in one or two symptoms. For most in the placebo group, symptoms remained the same or even worsened over the 48-hour period."

An article by Dr. Kong detailing the clinical study has been published in the peer-reviewed scientific journal Online Journal of Pharmacology and PharmacoKinetics. Dr. Kong holds a Ph.D. in Immunology from the University of Alabama at Birmingham and an M.D. from Hunan Medical University, People's R
'/>"/>

SOURCE HerbalScience Group LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era
2. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
3. Dont Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
4. Mirus Bio Releases for Sale TransIT(R)-2020; a New Broad Spectrum, Animal-Free Transfection Reagent to Go Head to Head With FuGENE(R) HD and Lipofectamine(TM) 2000
5. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
6. Engageon Releases First Peer-to-Peer Medical Association Social Network
7. Next Safety Releases Advanced Respirator for Infectious Diseases
8. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
9. PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The laboratory information management systems market ... number of technological advancements due to factors such as ... to integrate healthcare systems, and increasing government support for ... integration. Key players in the market focus on technological ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was ... Pre-Conference seminar on probiotics in San Diego, CA. , ... conference for health care professionals. This year’s pre-conference seminar was ... in health. Dr. Leyer spoke about the emerging topics and ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... SCOTTSDALE, Ariz., March 17, 2011 Delta Point, Inc., ... and developing business relationships, has named Ed Weimer as ... numerous awards for his ability to highly motivate, develop ... providing the strategic vision to contribute to the organization,s ...
... 2011 Genesis Biopharma, Inc. (OTC Bulletin ... targeted cancer therapies, today announced it has appointed William ... Andrews has three decades experience in biotechnology research and ... of Sierra Sciences, LLC, a company he founded in ...
... 2011 A first-of-its-kind study of gene therapy in ... all patients who received the treatment had "clinically meaningful ... "The study demonstrates that the promise of ... says study lead author and co-principal investigator Peter LeWitt, ...
Cached Biology Technology:Ed Weimer Joins Delta Point, Inc. as Executive Account Director 2Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors 2Study: 'Meaningful improvements' Using Gene Therapy in Parkinson's Disease 2Study: 'Meaningful improvements' Using Gene Therapy in Parkinson's Disease 3
(Date:12/22/2014)... (NASDAQ: NXTD and NXTDW) ("NXT-ID" or the ... commerce market, announces it has retained famous pickpocket, entertainer and ... CES debut of the Wocket™ biometric smart wallet.  ... booth January 6th and 7 th , 2015, demonstrating some ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... transmitted diseases (STDs) requires treatment of the sexual partners ... infected men with antibiotics to give their partners is ... the partners, according to an article in the Sept. ... Men with chlamydia or gonorrhea were more likely to ...
... into a tumor, seal the exits and detonate a ... cells unscathed. , MIT researchers have designed a nanoparticle ... "nanocell" proved effective and safe, with prolonged survival, against ... mice. , The work will be reported in the ...
... A new study released in Science (via Science Express ... in the diversity of fish in the open ocean ... Teasing apart the effects of climate change and fishing ... clear link to overfishing and highlight a surprising global ...
Cached Biology News:New study: Sexually transmitted disease treatment can be effectively administered by sex partners 2New study: Sexually transmitted disease treatment can be effectively administered by sex partners 3MIT engineers an anti-cancer smart bomb 2Scientists discover global pattern of big fish diversity in open oceans 2Scientists discover global pattern of big fish diversity in open oceans 3Scientists discover global pattern of big fish diversity in open oceans 4Scientists discover global pattern of big fish diversity in open oceans 5
... Phosphatase ( l-PPase) is ... with activity towards phosphorylated ... residues. It is the ... the ORF221 open reading ...
... ATP Monitoring Kit measures adenosine ... sensitivity and a dynamic range. ... the assay measures ATP in ... over a concentration range of ...
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Thermo Forma provides an array of accessory Racks for the Cryo/CryoPlus 16" Diameter storage system. To maximise inventory capacity a Jumbo Arrowhead configuration is recommended. You may choose betw...
Biology Products: